CD40LG and triple-negative breast carcinoma: Likewise, high CD40LG expression was associated with better survival in all breast cancer (hazard ratios of 0.71–0.89, P = 3.9e-05) and triple negative breast cancer (hazard ratios of 0.32–0.78, P = 0.0018) data set (Figure 1c and Figure 1d).